Rexahn Pharmaceuticals, Inc. to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference

ROCKVILLE, Md.--(BUSINESS WIRE)--

Rexahn Pharmaceuticals, Inc. (OTC BB:RXHN), a biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative treatments for cancer, central nervous system disorders, sexual dysfunction and other unmet medical needs, today announced that the company will be presenting an overview of Rexahn Pharmaceuticals at the Rodman & Renshaw 5th Annual Global Healthcare Conference to be held May 19-20, 2008 at the Le Meridien Beach Plaza Hotel in Monte Carlo, Monaco.

The company's Chairman and Chief Executive Officer, Dr. Chang H. Ahn, is scheduled to present an overview of Rexahn Pharmaceuticals on Tuesday, May 20, 2008 at 9:00am CEST in the Atlantique Salon, Meridional.

    The full conference schedule can be found on
www.rodmanrenshaw.com/eu08conference

About Rexahn Pharmaceuticals, Inc.

Rexahn Pharmaceuticals is a biopharmaceutical company leveraging its unique technology platform to discover, develop and commercialize innovative treatments for cancer, central nervous system disorders, sexual dysfunction and other unmet medical needs. Rexahn's compounds are designed to uniquely treat various disease states while significantly minimizing side effects in order to allow patients to regain quality of life through therapy. For Additional information about Rexahn visit www.rexahn.com

Source: Rexahn Pharmaceuticals, Inc.

Released May 13, 2008